Company intelligence / Profile preview

Cellomatics Biosciences

Nottingham, England, United Kingdomcellomaticsbio.com ↗

Ownership: Private
Development stage: Other

Overview

Cellomatics Biosciences provides bespoke preclinical in vitro bioassay services to support drug discovery and early development for global biotech and pharma clients. Their expertise spans oncology, immuno-oncology, immunology/inflammation and respiratory disease. They offer complex cell-based models including monocultures/co-cultures/3D cultures for target validation, toxicity profiling and biomarker qualification. No clinical results as they are a service provider CRO.

Therapeutic areas: OncologyPulmonologyImmunology
Modalities: AntibodyAntisense oligonucleotideSmall interfering RNASmall moleculeBiologic
Industry: Drug Discovery Services

Partnerships

Strategic relationship with the University of Leicester

Beyond the preview

Go deeper on Cellomatics Biosciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cellomatics Biosciences.

Explore the full profile